{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:59:32Z","timestamp":1770973172331,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jacl.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T02:59:08Z","timestamp":1515725948000},"page":"305-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["The prevalence and etiology of extreme hypertriglyceridemia in children: Data from a tertiary children's hospital"],"prefix":"10.1016","volume":"12","author":[{"given":"Nivedita","family":"Patni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley","family":"Adams-Huet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhimanyu","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2018.01.003_bib1","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2018.01.003_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0025-7125(16)31430-4","article-title":"Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia","volume":"66","author":"Brunzell","year":"1982","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jacl.2018.01.003_bib3","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jacl.2016.04.001","article-title":"Type 1 hyperlipoproteinemia in a child with large homozygous deletion encompassing GPIHBP1","volume":"10","author":"Patni","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.01.003_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jacl.2014.02.006","article-title":"Genotype-phenotype relationships in patients with type I hyperlipoproteinemia","volume":"8","author":"Chokshi","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.01.003_bib5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjcard.2010.11.008","article-title":"Prevalence of severe (500 to 2,000 mg\/dL) hypertriglyceridemia in United States adults","volume":"107","author":"Christian","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2018.01.003_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10545-011-9406-5","article-title":"Deletion of GPIHBP1 causing severe chylomicronemia","volume":"35","author":"Rios","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2018.01.003_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12944-017-0511-9","article-title":"Severe hypertriglyceridemia in Norway: prevalence, clinical and genetic characteristics","volume":"16","author":"Retterstol","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2018.01.003_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacl.2014.08.010","article-title":"Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1","volume":"8","author":"Ahmad","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.01.003_bib9","article-title":"Familial lipoprotein lipase deficiency","author":"Burnett","year":"1993"},{"key":"10.1016\/j.jacl.2018.01.003_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jacl.2017.03.015","article-title":"Extreme hypertriglyceridemia, pseudohyponatremia, and pseudoacidosis in a neonate with lipoprotein lipase deficiency due to segmental uniparental disomy","volume":"11","author":"Ashraf","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2018.01.003_bib11","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2018.01.003_bib12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/sj.leu.2400703","article-title":"Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity","volume":"11","author":"Hoogerbrugge","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.jacl.2018.01.003_bib13","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood.V89.6.1886","article-title":"Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia","volume":"89","author":"Parsons","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jacl.2018.01.003_bib14","first-page":"351","article-title":"Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma","volume":"27","author":"Tozuka","year":"1997","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.jacl.2018.01.003_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/pbc.26559","article-title":"Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents","volume":"64","author":"Persson","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jacl.2018.01.003_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism","volume":"43","author":"Geer","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.jacl.2018.01.003_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000314213","article-title":"Pathophysiology of dyslipidemia in Cushing's syndrome","volume":"92 Suppl 1","author":"Arnaldi","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jacl.2018.01.003_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem-57-3-619","article-title":"Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome","volume":"57","author":"Taskinen","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2018.01.003_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2008.03.026","article-title":"Cyclosporine A and Rapamycin induce in\u00a0vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma","volume":"358","author":"Tory","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jacl.2018.01.003_bib20","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/S0041-1345(00)01884-4","article-title":"Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia","volume":"32","author":"Tur","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jacl.2018.01.003_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/JCP.0b013e31817efb99","article-title":"Reversible elevation of triglycerides in dual-diagnosis patients taking aripiprazole: a case series","volume":"28","author":"Tolliver","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jacl.2018.01.003_bib22","first-page":"4","article-title":"Aripiprazole-induced hyperlipidemia: an update","volume":"18","author":"Tarraf","year":"2016","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.jacl.2018.01.003_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/BF01709533","article-title":"Hypertriglyceridaemia associated with propofol sedation in critically ill patients","volume":"22","author":"Mateu","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacl.2018.01.003_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF01720682","article-title":"The effect on serum lipid concentrations of\u00a0a prolonged infusion of propofol\u2013hypertriglyceridaemia associated with propofol administration","volume":"17","author":"Eddleston","year":"1991","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacl.2018.01.003_bib25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00134-003-1905-x","article-title":"The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome","volume":"29","author":"Vasile","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jacl.2018.01.003_bib26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM199110243251702","article-title":"Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins","volume":"325","author":"Walsh","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2018.01.003_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00002018-200124060-00003","article-title":"Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels","volume":"24","author":"Mantel-Teeuwisse","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacl.2018.01.003_bib28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1365-2133.1993.tb03336.x","article-title":"Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests","volume":"129","author":"Barth","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacl.2018.01.003_bib29","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418300230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287418300230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T14:31:12Z","timestamp":1603636272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287418300230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1933287418300230"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2018.01.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence and etiology of extreme hypertriglyceridemia in children: Data from a tertiary children's hospital","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}